- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.94 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x K: POTASSIUM ION(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
ACT.2: 9 residues within 4Å:- Chain A: M.450, N.451, D.452, L.455, K.456, Y.459
- Chain B: V.243, R.246, R.247
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:K.456, A:Y.459
- Hydrogen bonds: A:D.452, A:Y.459
- Salt bridges: B:R.247
ACT.7: 6 residues within 4Å:- Chain A: R.247
- Chain B: M.450, N.451, D.452, K.456, Y.459
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:K.456, B:Y.459
- Hydrogen bonds: B:D.452, B:Y.459, B:Y.459
- Salt bridges: A:R.247
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.3: 24 residues within 4Å:- Chain A: T.129, W.130, N.131, L.136, E.157, L.158, V.186, T.189, T.203, G.204, S.205, V.208, I.211, E.226, L.227, G.228, C.260, R.305, H.306, E.350, F.352, L.378, F.418
- Ligands: 1DD.4
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:T.129, A:L.136, A:T.203
- Hydrogen bonds: A:T.129, A:E.157, A:S.205, A:S.205, A:E.226, A:L.227, A:R.305, A:E.350
- Water bridges: A:W.130, A:K.154, A:S.156, A:T.190, A:Y.202, A:Y.202, A:Y.202, A:Y.202, A:G.229, A:H.306, A:E.350
- Salt bridges: A:H.306
NAD.8: 22 residues within 4Å:- Chain B: T.129, W.130, N.131, L.136, E.157, L.158, V.186, T.203, G.204, S.205, V.208, I.211, E.226, L.227, G.228, C.260, H.306, E.350, F.352, L.378, F.418
- Ligands: 1DD.9
13 PLIP interactions:13 interactions with chain B- Hydrophobic interactions: B:T.129, B:L.136, B:T.203
- Hydrogen bonds: B:T.129, B:E.157, B:S.205, B:L.227, B:E.350
- Water bridges: B:W.130, B:S.156, B:T.190, B:G.229
- Salt bridges: B:H.306
- 2 x 1DD: 1-[(4-fluorophenyl)sulfonyl]-2-methyl-1H-benzimidazole(Non-covalent)
1DD.4: 14 residues within 4Å:- Chain A: E.78, E.79, Y.82, Y.132, N.135, L.136, M.254, C.260, I.408, I.411, T.412, F.418, H.430
- Ligands: NAD.3
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:Y.82, A:Y.82, A:Y.132, A:Y.132, A:L.136, A:L.136, A:I.408, A:I.411, A:T.412, A:F.418
1DD.9: 14 residues within 4Å:- Chain B: E.78, E.79, Y.82, Y.132, N.135, L.136, Q.139, M.254, C.260, I.408, I.411, F.418, H.430
- Ligands: NAD.8
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:Y.82, B:Y.82, B:Y.82, B:Y.132, B:Y.132, B:L.136, B:L.136, B:I.408, B:I.411, B:F.418, B:F.418
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parajuli, B. et al., Crystal structure of human ALDH3A1 with its selective inhibitor 1-(4-fluorophenyl)sulfonyl-2-methylbenzimidazole. J.Med.Chem. (2014)
- Release Date
- 2014-01-29
- Peptides
- Aldehyde dehydrogenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.94 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x K: POTASSIUM ION(Non-covalent)
- 2 x ACT: ACETATE ION(Non-functional Binders)
- 2 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x 1DD: 1-[(4-fluorophenyl)sulfonyl]-2-methyl-1H-benzimidazole(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parajuli, B. et al., Crystal structure of human ALDH3A1 with its selective inhibitor 1-(4-fluorophenyl)sulfonyl-2-methylbenzimidazole. J.Med.Chem. (2014)
- Release Date
- 2014-01-29
- Peptides
- Aldehyde dehydrogenase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
G